Moderately severe hemophilia A
MONDO:0015720Moderately severe hemophilia A is a form of hemophilia A characterized by factor VIII deficiency leading to abnormal bleeding as a result of minor injuries, or following surgery or tooth extraction.
Also known as: moderately severe factor VIII deficiency, moderately severe haemophilia type A, moderately severe hemophilia type A
17 clinical trials for this condition and its sub-types, 4 tagged with Moderately severe hemophilia A itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New shot could reduce bleeds in hemophilia a patients
Disease control Recruiting nowThis Phase 3 trial tests a new drug called NXT007 (Zemocimig) against standard Factor VIII treatment to prevent bleeding in people with severe or moderate hemophilia A who do not have inhibitors. About 126 participants aged 12 and older will receive either NXT007 as a shot under …
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New clotting factor offers continued bleeding control for hemophilia a patients
Disease control Recruiting nowThis study gives people with moderate or severe hemophilia A who finished a previous trial continued access to the drug efanesoctocog alfa. The drug is a lab-made clotting factor that helps prevent bleeding episodes. Researchers will monitor safety and how well it controls bleedi…
Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC